Skip to main content


  • Sunday, Aug 24th
    11:30 AM - 11:45 AM ET
    1G-05 - Using Aggregate Historical Control Data to Assess the Effects of New Treatments: An Illustrative Example of Population Adjusted Indirect Comparisons
    Presenting Author: Jack Ishak, PhD – PPD Evidera Health Economics & Market Access, Thermo Fisher Scientific
    Co-Author: Susan A. Oliveria, ScD, MPH, FISPE – PPD Observational Studies, Thermo Fisher Scientific
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    11:45 AM - 12:00 PM ET
    1G-06 - Cross-Site Imputation for Recovering Variables without Individual Pooled Data
    Presenting Author: Robert Thiesmeier – Karolinska Institutet
    Co-Author: Paul Madley-Dowd – Bristol University
    Co-Author: Nicola Orsini – Karolinska Institutet
    Co-Author: Viktor Ahlqvist – Aarhus University
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    3:30 PM - 3:45 PM ET
    2E-01 - A weighting method to remove bias due to within-subject exposure dependency when the exposure has multiple levels in case-crossover studies: A simulation study
    Presenting Author: Kiyoshi Kubota – NPO Drug Safety Research Unit Japan
    Co-Author: Tsugumichi Sato – Tokyo University of Science
    Co-Author: Thu-Lan Kelly – Quality Use of Medicines Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    3:30 PM - 3:45 PM ET
    2F-01 - Validation and Extension of IPW-Adjusted Cox Regression Using Super Learning: Insights from Antihypertensive and Antihyperlipidemic Therapy Comparisons
    Presenting Author: Sumaira Mubarik – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
    Co-Author: Xuechun Li – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
    Co-Author: Eelko Hak – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    3:45 PM - 4:00 PM ET
    2E-02 - Comparison of Approaches for Regression Discontinuity Analysis of the Effect of a Treatment Policy for Statin Prescribing on Atherosclerotic Cardiovascular Disease Incidence
    Presenting Author: Wentao Li – JPS Health Network
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    4:00 PM - 4:15 PM ET
    2F-03 - Benefits of Machine Learning Methods for Identifying Clinical Features and Patient Characteristics Associated with Treatment Outcomes in Autoimmune Conditions
    Presenting Author: Heather Litman – CorEvitas, LLC
    Co-Author: Scott Henderson – CorEvitas, LLC
    Co-Author: Andrea Austin – CorEvitas, LLC
    Co-Author: Yolanda Munoz Maldonaldo, PhD – CorEvitas, LLC
    Co-Author: Robert R. McLean – CorEvitas, LLC
    Co-Author: Melissa Eliot – CorEvitas, LLC
    Co-Author: Miao Yu – CorEvitas, LLC
    Co-Author: Sandra I. Main, MPH – CorEvitas, LLC
    Co-Author: Tyan Aleshire, BS – CorEvitas, LLC
    Co-Author: Denise Bennett Mason – CorEvitas, LLC
    Co-Author: Leslie Harrold, MD, MPH – CorEvitas, LLC
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    4:15 PM - 4:30 PM ET
    2E-04 - Comparison of Estimators of the Natural Direct Effect Under Model Misspecification: A Monte Carlo Simulation Analysis
    Presenting Author: Kyle Johnson, MSc – 1 Department of Epidemiology, Biostatistics and Occupational Health, McGill University
    Co-Author: Sarah Beradid, MSc – Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
    Co-Author: James M. Brophy, MD, PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University
    Co-Author: Janie Coulombe – Department of mathematics and statistics, Universite de Montreal
    Co-Author: Christel Renoux, MD, PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University
    Co-Author: Robert W. Platt, PhD – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
    Methods in Pharmacoepidemiology / Analytical Methods
  • Sunday, Aug 24th
    4:15 PM - 4:30 PM ET
    2F-04 - Tree-based Scan Statistics to Evaluate Drug Safety in Pediatric Populations: Sulfamethoxazole/trimethoprim as a Positive Test Case
    Presenting Author: Kelly Fung – Brigham and Women's Hospital
    Co-Author: Loreen Straub – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Timothy Savage, MD, MPH, MSc – Brigham and Women's Hospital / Boston Children's Hospital
    Co-Author: Massimiliano Russo, PhD, MS – Ohio State University
    Co-Author: Helen Mogun – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Thomas Deramus – Brigham and Women's Hospital
    Co-Author: Georg Hahn, PhD – Brigham and Women's Hospital
    Co-Author: Shirley V. Wang – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Krista Huybrechts – Brigham and Women's Hospital and Harvard Medical School
    Methods in Pharmacoepidemiology / Analytical Methods
  • Monday, Aug 25th
    9:00 AM - 9:15 AM ET
    3D-04 - Pruning to increase computational efficiency for tree-based scan statistics
    Presenting Author: Georg Hahn, PhD – Brigham and Women's Hospital
    Co-Author: Massimiliano Russo, PhD, MS – Ohio State University
    Co-Author: Shirley V. Wang – Brigham and Women's Hospital, Harvard Medical School
    Methods in Pharmacoepidemiology / Analytical Methods
  • Monday, Aug 25th
    9:30 AM - 9:45 AM ET
    3D-06 - Benchmarking Large Language Models and Optical Character Recognition to Enhance Network Meta-Analyses
    Presenting Author: Andy Dang – Eli Lilly and Company
    Co-Author: Ameeta` Agrawal – Portland State University
    Co-Author: Mingyang Shan – Eli Lilly and Company
    Methods in Pharmacoepidemiology / Analytical Methods
  • Monday, Aug 25th
    4:45 PM - 5:00 PM ET
    4G-03 - Comparison of Propensity Score Matching vs. Inverse Probability Treatment Weighting: A Simulation Study in the CorEvitas Psoriasis Registry
    Presenting Author: Sarah Mansfield, MS – CorEvitas, LLC
    Co-Author: Michael Singleton, PhD – CorEvitas, LLC
    Co-Author: Melissa Moore-Clingenpeel – CorEvitas
    Co-Author: Leslie Harrold, MD, MPH – CorEvitas, LLC
    Co-Author: Heather Litman – CorEvitas, LLC
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    8:45 AM - 9:00 AM ET
    5B-02 - Integrate Real-World Data and Genetics: A Causal Machine Learning Approach to Assess Heterogeneous Treatment Effect of Statins on Alzheimer's Disease
    Location: Ballroom AB
    Presenting Author: Yongjie Lai – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University
    Co-Author: Tiansheng Wang, PharmD, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Elizabeth Mormino – Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
    Co-Author: Guorong Wu – Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill
    Co-Author: Gwenn Anne Garden – Department of Neurology, School of Medicine, University of North Carolina at Chapel Hill
    Co-Author: Til Stürmer, MD, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Yang Xu – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    9:15 AM - 9:30 AM ET
    5B-04 - To Clone or Not to Clone? Baseline Incompatibility with Regimens when Cloning, Censoring, and Weighting
    Presenting Author: Michael Webster-Clark – Wake Forest University
    Co-Author: Gwen Aubrac, MscPH – McGill University
    Co-Author: Robert W. Platt, PhD – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
    Co-Author: Alexander Breskin – Regeneron Pharmaceuticals, Inc.
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    1:30 PM - 1:45 PM ET
    6E-01 - Calculating number needed to treat (NNT) for studies using real world data with variable follow-up times: Kaplan-Meier versus rate-based approach
    Presenting Author: Sarah R. Hoffman – Carelon Research
    Co-Author: Stephan Lanes – Carelon Research
    Co-Author: Tracey Quimbo – Carelon Research
    Co-Author: Anahit Papazian – Carelon Research
    Co-Author: Jeff White – CarelonRx
    Co-Author: Vicki Fisher – CarelonRx
    Co-Author: Mark Cziraky – Carelon Research
    Co-Author: Matthew Crowley – Duke University Medical Center
    Co-Author: Vincent Willey – Carelon Research
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    1:30 PM - 1:45 PM ET
    6F-01 - One Disease, Three Definitions: Unpacking the Impact of Cohort Entry Date Choice on Type 2 Diabetes Identification Using Claims
    Presenting Author: Ping Shao, MS – Regeneron Pharmaceuticals, Inc.
    Co-Author: Xinyue Liu, PhD, MS – Regeneron Pharmaceuticals, Inc.,
    Co-Author: Shiyao Gao – Regeneron Pharmaceuticals Inc.
    Co-Author: Julius Asubonteng – Regeneron Pharmaceuticals, Inc.
    Co-Author: Andrea Marcus – Regeneron
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    1:30 PM - 1:45 PM ET
    6G-01 - The ECHO Study: Evaluation of Cloning-Censor-Weighting to assess the effect of time to treatment initiation of single inhaler dual ICS/LABA therapy after a first observed COPD diagnosis in the United States
    Co-Author: Stefan Franzén, PhD – BPM Evidence Statistics, Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
    Presenting Author: Awa Diop, PhD – Real World Data Science, BioPharmaceuticals Medical, Mississauga, Canada
    Co-Author: Michael Pollack, PhD – Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, US
    Co-Author: Achim Wolf, PhD – Data Analytics - Real World Evidence, Evidera, London, United Kingdom
    Methods in Pharmacoepidemiology / Analytical Methods
  • Tuesday, Aug 26th
    2:45 PM - 3:00 PM ET
    6E-06 - Heterogeneity of treatment effects for GLP1-RA on kidney outcomes in patients with type 2 diabetes mellitus
    Presenting Author: Yang Xu – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
    Co-Author: Tao Huang – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
    Co-Author: Ruyu Li – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
    Co-Author: Zhuoheng Shen – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China
    Co-Author: Edouard L. Fu – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    Co-Author: Juan-Jesus Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
    Methods in Pharmacoepidemiology / Analytical Methods